Gomes Sonia Da Rocha, Azéma Laurent, Allard Michèle, Toulmé Jean-Jacques
Novaptech, 2 rue Robert Escarpit, 33607 Pessac, France.
Expert Opin Med Diagn. 2010 Nov;4(6):511-8. doi: 10.1517/17530059.2010.516248. Epub 2010 Sep 27.
Aptamers are structured oligonucleotides able to bind with high affinity and specificity a wide range of targets. Over the last decade, aptamers have been developed as targeting agents for diagnostics. Advances in imaging methods have led to a new generation of targeting molecules such as aptamer-based probes.
Aptamers are selected through a combinatorial strategy termed SELEX (systematic evolution of ligands by exponential enrichment), and can be easily modified for generating new diagnostic tools or therapeutic agents. These modifications increase the nuclease resistance and improve the in vivo bioavailability, and conjugations of aptamer to appropriate labels provide colorimetric, fluorescent, or radiolabeled aptamers for the detection of cancer-related antigens.
This review reports on the different aptamer-based imaging probes developed for ex vivo and in vivo applications. The advantages and challenges in developing aptamer-based probes will be discussed.
The applications of aptamers range from diagnostic to therapeutic. Their binding properties, retention in the tumor region and clearance properties make them relevant tumor imaging probes.
适体是能够以高亲和力和特异性结合多种靶标的结构化寡核苷酸。在过去十年中,适体已被开发用作诊断的靶向剂。成像方法的进步催生了新一代靶向分子,如基于适体的探针。
适体是通过一种称为SELEX(指数富集配体的系统进化)的组合策略筛选出来的,并且可以很容易地进行修饰以生成新的诊断工具或治疗剂。这些修饰提高了核酸酶抗性并改善了体内生物利用度,将适体与适当的标记物偶联可提供用于检测癌症相关抗原的比色、荧光或放射性标记适体。
本综述报道了为体外和体内应用开发的不同的基于适体的成像探针。将讨论开发基于适体的探针的优点和挑战。
适体的应用范围从诊断到治疗。它们的结合特性、在肿瘤区域的滞留和清除特性使其成为相关的肿瘤成像探针。